Key facts
- It has raised $3.6M; the latest was Later Stage VC ($3.6M) in Jan 2026.
- Notable investors include Shandong Finance Group, Dongying Caijin Investment Group.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Benyue Biological
- ·The full record, as it builds
Funding rounds
No funding rounds for Benyue Biological are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Benyue Biological
Manufacturer of bio-based, natural and non-nutritive sweeteners designed to support healthier sugar reduction and functional ingredient development. The company offers citrus-derived sweeteners and high-value active ingredients produced through synthetic biology and biomanufacturing platforms, enabling food and beverage producers to achieve stable sweetness profiles with improved safety and functional performance.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Zibo, China
- Founded
- 2014
- Employees
- 74
- Website
- benyuekj.cn/
- Ownership
- Privately Held (backing)
Benyue Biological doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Benyue Biological shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Benyue Biological in its N-PORT filings yet. We sweep new filings monthly.